Q3 Round Up:Two out of Three Ain’t Bad

Q3 Round Up:

Two out of
Three Ain’t Bad

OCTOBER 2024Headwinds like the Inflation Reduction Act (IRA) are going nowhere and are joined by new legislative moves such as the BIOSECURE Act, which continues to fuel uncertainty. Add to that the looming US election, geopolitical challenges around the...Contents

Foreword

Quarterly IPOs Climb Back Above $1bn

VC Funding Dips In Q3, But 2024 Already Bests Full-Year 2023

M&A Took A Holiday In Q3, With Decreased Volume And Value

HOW WE HELP

Evaluate Headquarters
Evaluate Ltd.
3 More London
London SE1 2RE
United Kingdom
T +44 (0)20 7377 0800

Evaluate Americas
EvaluatePharma USA Inc.
265 Franklin, Suite 1101
Boston, MA 02109
USA
T +1 617 573 9450

Evaluate Asia Pacific
Evaluate Japan KK
Shin Marunouchi Center Building

6-2 Marunouchi 1-chome, Chiyoda-ku
Tokyo 105-0001, Japan
T +81 (0)70 4131 0112